The next-generation sequencing market is estimated to grow at a CAGR of 21.1% during the forecast period from 2018 to 2025. The next-generation sequencing market is estimated to reach US $ 26,501.25 million by 2025.
This survey provides a comprehensive 360-degree analysis of the next generation sequencing market and provides insights that help stakeholders identify opportunities and challenges. Track global next-generation sequencing markets across key regions and provide detailed commentary and accurate quantitative insights. The study also includes a sharp and competitive landscape analysis that provides marketers with important recommendations on the need to win and strategies to succeed.
Get a PDF sample copy: https://www.theinsightpartners.com/sample/TIPHE100000820/
Next Generation Sequencing (NGS) is a technology used to align millions of small DNA fragments simultaneously that can process multiple DNA sequences in parallel. The advent of rapid DNA sequencing has significantly enhanced biological and medical research and discovery. The demand for next-generation sequencing technology has increased significantly due to the increase in genetic testing. Availability of next-generation sequencing at low cost, technological advances, and high prevalence of cancer cases over the past few years. In addition, companies that operate next-generation sequencing markets have invested a significant amount of time and amount in research and development activities, which allows them to introduce better technologies to the market.
The next-generation sequencing market has seen healthy growth over the past few years and is expected to see similar trends in the coming years. Companies operating in the next-generation sequencing market provide products and services for applications such as drug discovery, diagnostics and precision medicine. Through constant research and development activities, companies are focusing on developing advanced technologies for next-generation sequencing that are useful for end users such as hospitals, clinics, and academic institutions. Various players are upgrading their product portfolios with approval requests. Through expansion activities, companies are focusing on strengthening their customer base by serving a variety of applications.
F is a major player in the next generation sequencing market. Hoffmann-La Roche AG, PerkinElmer, Inc., Oxford Nanopore Technologies, Ltd., Eurofins Scientific, Thermo Fisher Scientific, Beijing Genomics Institute, Agilent Technologies, Qiagen NV, Macrogen, Inc., and Illumina, Inc.
Next Generation Sequencing The market is well established in North America, especially in the United States and Canada. Companies are working on expansion activities to strengthen their customer presence in the North American region. Illumina, Inc. and Telegraph, for example, have jointly launched Verogen, a new company that provides Illumina forensic sequencing technology to US forensic clients. . Technological advances and price drops are considered the driving force for the next generation sequencing market.
Buy a complete report with a comprehensive table of contents @ https://www.theinsightpartners.com/buy/TIPHE100000820/
Our research breaks down the next-generation sequencing market by product, service, application, and end user. The products considered in this study are platforms, services, and consumables. The platform segment is further subdivided into Hiseq, Miseq, Solid, ION Torrent, Pacbio Rs II and Sequel Systems. The service sub-segment is further divided into sequencing services and data management and analysis services. Consumables are further branched as sample preparation consumables, library preparation and target enrichment kits and reagents, quality control kits and reagents. Service segments are classified as genome sequences. Exome sequencing, resequencing & target sequencing, and other services. Next-generation sequencing applications included in the report include diagnostics, drug discovery, and precision medicine. Next-generation sequencing end users are categorized into academic and research institutions, pharmaceutical and biotechnology companies, hospitals and clinics. Geographically, the next generation sequencing market is broken down into North America, Europe, Asia Pacific (APC), Middle East and Africa (MEA), South and Central America (S & CAM).
Insight Partners is a one-stop industry research provider of actionable intelligence. We help customers get solutions to their research requirements through syndicated and consulting research services. We are technology, healthcare, manufacturing, automotive and defense specialists.
Phone: + 1-646-491-9876
Web: https: // www